- Home
- ROIV vs RIVN Comparison
ROIV vs RIVN Comparison
Compare ROIV & RIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | RIVN |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 23.1B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ROIV | RIVN |
|---|---|---|
| Price | $28.05 | $14.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 21 |
| Target Price | ★ $27.56 | $17.89 |
| AVG Volume (30 Days) | 4.8M | ★ 26.2M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.54 |
| EPS | ★ N/A | N/A |
| Revenue | $29,053,000.00 | ★ $5,387,000,000.00 |
| Revenue This Year | N/A | $33.90 |
| Revenue Next Year | $385.85 | $63.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 8.39 |
| 52 Week Low | $8.73 | $10.36 |
| 52 Week High | $30.33 | $22.69 |
Technical Indicators
Market Signals| Indicator | ROIV | RIVN |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 44.19 |
| Support Level | $26.94 | $14.62 |
| Resistance Level | N/A | $16.17 |
| Average True Range (ATR) | 1.01 | 0.74 |
| MACD | -0.21 | 0.07 |
| Stochastic Oscillator | 32.70 | 11.77 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About RIVN Rivian Automotive Inc.
Rivian is a battery electric vehicle automaker that sells its vehicles in the US and Canada. The company also develops electronic control units and related software for autos in a joint venture with Volkswagen. Rivian has multiple vehicles in its fleet, which include a luxury truck and full-size SUV and a delivery van. The company also plans to begin selling a midsize SUV in 2026. Total deliveries were nearly 52,000 in 2024. Rivian is also developing autonomous driving software to be used in its vehicles.